Shattuck Labs Email Format
Biotechnology ResearchTexas, United States51-200 Employees
Shattuck Labs is a biotechnology company focused on developing antibody-based therapies for inflammatory and immune-mediated diseases, including inflammatory bowel disease. Its lead program, SL-325, aims to block the TL1A/DR3 signaling axis more completely and durably, reflecting a focus on TNF receptor pathways and protein engineering. The company is based in Austin, Texas, with additional offices in Durham, North Carolina. As a mid-sized organization, Shattuck Labs participates in industry forums and has taken part in panel discussions at events such as UEG Week 2025 and ECCO 2025.